Recent studies have reported that ALKBH5 suppressed antitumor T cells by inhibiting PD-L1 mRNA degradation in N6-methyladenosine modification in intrahepatic cholangiocarcinoma [28]. Here, ALKBH5 is linked to intrahepatic cholangiocarcinoma.